Templeton Global Income Fund
Change company Symbol lookup
Select an option...
GIM Templeton Global Income Fund
NSTC Northern Star Investment Corp III
WMLLF Wealth Minerals Ltd
NVVE Nuvve Holding Corp
ICCC ImmuCell Corp
MET MetLife Inc
FAST Fastenal Co
PFTA Portage Fintech Acquisition Corp
SMLP Summit Midstream Partners LP
GFOR Graf Acquisition Corp IV
Go

Company profile

Templeton Global Income Fund (the Fund) is a non-diversified, closed-end management investment company. The Fund seeks high, current income, with a secondary goal of capital appreciation. Under normal conditions, the Fund invests at least 80% of its net assets in income-producing securities, including debt securities of the United State and foreign issuers, including emerging markets. The Funds income-producing securities include derivative instruments or other instruments that have economic characteristics similar to such securities. The Fund invests in derivative financial instruments in order to manage risk or gain exposure to various other instruments or markets. Franklin Advisers, Inc. is the Fund's investment manager.

Price
Delayed
$4.16
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
4.18
Day's Low
4.14
Volume
(Light)

Today's volume of 68,136 shares is on pace to be much lighter than GIM's 10-day average volume of 315,680 shares.

68,136

TherapeuticsMD Inc. Stock Falls Monday, Underperforms Market

5:25 pm ET August 22, 2022 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of TherapeuticsMD Inc. (TXMD) slid 4.00% to $9.59 Monday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 2.55% to 12,381.57 and Dow Jones Industrial Average falling 1.91% to 33,063.61. This was the stock's second consecutive day of losses. TherapeuticsMD Inc. closed $33.77 short of its 52-week high ($43.36), which the company achieved on August 25th.

The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson (JNJ) fell 0.35% to $167.59, Merck & Co. Inc. (MRK) fell 1.00% to $91.16, and Novartis AG ADR (NOVN.EB) fell 1.60% to $84.39. Trading volume (133,223) remained 826,887 below its 50-day average volume of 960,110.

Data source: Dow Jones Market Data, FactSet. Data compiled August 22, 2022.

	

(END) Dow Jones Newswires

August 22, 2022 17:25 ET (21:25 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.